Clinical Trials
88 trialsENDOLA
Hospices Civils de Lyon
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
M.D. Anderson Cancer Center
Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma
Sohag University
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
PRSTEC_multipr
University Hospital Hradec Kralove
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Tampere University Hospital
TREAT-EC
Rutgers, The State University of New Jersey
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
M.D. Anderson Cancer Center
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
M.D. Anderson Cancer Center
V-COSMOS
Cukurova University
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
PostOP HYPOCxE
Siriraj Hospital
TTBF
University of California, San Francisco
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mayo Clinic
Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Failure of First-Line Therapy With Platinum-based Doublet and Immunotherapy
University of Miami
RAINBO
Leiden University Medical Center
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Peking University First Hospital
N01-A-PICIT-GT
Peking University People's Hospital
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
Memorial Sloan Kettering Cancer Center
Endometrial Cell Collection With the PadKit
Hackensack Meridian Health
Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding
University of Aarhus
SHAPE-ENDO
Hospital Universitari de Bellvitge
ARTISAN
Peking Union Medical College Hospital
GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
University of Southern California
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
MIRA
University of British Columbia
Reiki-Brachy
University of Utah
FIERCE
University of Oklahoma
GEORGIA
Ohio State University Comprehensive Cancer Center
DOVE
Yonsei University
iCaRe2
University of Nebraska
MANEC
Universita di Verona
PAM-II
University Medical Center Groningen
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
ENDOCancerDATA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
REPLACE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SISTER
University of Washington
Tirzepatide in Obesity-Driven Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Shandong Cancer Hospital and Institute
LYNX-EYE
San Raffaele University
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
Mayo Clinic
ANGELICA
Centre Leon Berard
Vaginal Cuff Brachytherapy Fractionation Study
University of Virginia
ECHO
Mayo Clinic
DETECTR
University of British Columbia
AH-HA
Wake Forest University Health Sciences
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
M.D. Anderson Cancer Center
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham